Nevro (NVRO) Competitors $4.57 +0.07 (+1.58%) As of 01/17/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends NVRO vs. KIDS, TMCI, SMLR, CLPT, NNOX, TCMD, DCTH, ZIMV, CVRX, and NPCEShould you be buying Nevro stock or one of its competitors? The main competitors of Nevro include OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), Semler Scientific (SMLR), ClearPoint Neuro (CLPT), Nano-X Imaging (NNOX), Tactile Systems Technology (TCMD), Delcath Systems (DCTH), ZimVie (ZIMV), CVRx (CVRX), and NeuroPace (NPCE). These companies are all part of the "medical equipment" industry. Nevro vs. OrthoPediatrics Treace Medical Concepts Semler Scientific ClearPoint Neuro Nano-X Imaging Tactile Systems Technology Delcath Systems ZimVie CVRx NeuroPace Nevro (NYSE:NVRO) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, community ranking, dividends, institutional ownership, valuation, analyst recommendations, media sentiment, profitability and earnings. Which has stronger valuation and earnings, NVRO or KIDS? OrthoPediatrics has lower revenue, but higher earnings than Nevro. OrthoPediatrics is trading at a lower price-to-earnings ratio than Nevro, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNevro$425.17M0.40-$92.21M-$1.89-2.42OrthoPediatrics$148.73M4.42-$20.97M-$1.23-22.08 Do analysts rate NVRO or KIDS? Nevro presently has a consensus price target of $6.30, suggesting a potential upside of 37.83%. OrthoPediatrics has a consensus price target of $39.00, suggesting a potential upside of 43.59%. Given OrthoPediatrics' stronger consensus rating and higher possible upside, analysts clearly believe OrthoPediatrics is more favorable than Nevro.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nevro 3 Sell rating(s) 10 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.77OrthoPediatrics 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Do insiders and institutionals have more ownership in NVRO or KIDS? 95.5% of Nevro shares are owned by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are owned by institutional investors. 3.2% of Nevro shares are owned by company insiders. Comparatively, 31.8% of OrthoPediatrics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media favor NVRO or KIDS? In the previous week, OrthoPediatrics had 2 more articles in the media than Nevro. MarketBeat recorded 12 mentions for OrthoPediatrics and 10 mentions for Nevro. OrthoPediatrics' average media sentiment score of 0.40 beat Nevro's score of -0.06 indicating that OrthoPediatrics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nevro 0 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral OrthoPediatrics 3 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, NVRO or KIDS? Nevro has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500. Comparatively, OrthoPediatrics has a beta of 1.14, indicating that its stock price is 14% more volatile than the S&P 500. Is NVRO or KIDS more profitable? OrthoPediatrics has a net margin of -15.00% compared to Nevro's net margin of -16.54%. OrthoPediatrics' return on equity of -5.78% beat Nevro's return on equity.Company Net Margins Return on Equity Return on Assets Nevro-16.54% -23.52% -10.83% OrthoPediatrics -15.00%-5.78%-4.80% Does the MarketBeat Community favor NVRO or KIDS? Nevro received 192 more outperform votes than OrthoPediatrics when rated by MarketBeat users. However, 64.26% of users gave OrthoPediatrics an outperform vote while only 63.11% of users gave Nevro an outperform vote. CompanyUnderperformOutperformNevroOutperform Votes50363.11% Underperform Votes29436.89% OrthoPediatricsOutperform Votes31164.26% Underperform Votes17335.74% SummaryOrthoPediatrics beats Nevro on 14 of the 17 factors compared between the two stocks. Get Nevro News Delivered to You Automatically Sign up to receive the latest news and ratings for NVRO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NVRO vs. The Competition Export to ExcelMetricNevroSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$123.28M$4.55B$5.24B$19.38BDividend YieldN/A47.31%5.13%3.71%P/E RatioN/A14.7559.9034.27Price / Sales0.4058.281,218.5317.03Price / CashN/A50.1443.8219.84Price / Book0.567.795.325.76Net Income-$92.21M$13.87M$122.69M$993.25M7 Day Performance39.36%1.46%-0.17%3.26%1 Month Performance27.33%12.36%3.49%5.71%1 Year Performance-75.44%32.40%25.79%18.85% Nevro Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NVRONevro2.6542 of 5 stars$4.57+1.6%$6.30+37.8%-74.8%$123.28M$425.17M0.001,215Gap UpKIDSOrthoPediatrics4.0191 of 5 stars$24.69+1.0%$39.00+58.0%-4.2%$597.89M$189.67M-20.07200Analyst ForecastShort Interest ↑News CoverageTMCITreace Medical Concepts0.8697 of 5 stars$8.39+14.9%$8.98+7.1%-31.4%$522.67M$202.86M-8.47250Gap UpSMLRSemler Scientific1.1039 of 5 stars$51.86+1.0%N/A+46.4%$480.59M$58.94M25.30120News CoverageGap UpCLPTClearPoint Neuro0.5935 of 5 stars$15.41+5.0%$11.33-26.5%+96.6%$425.09M$30.43M-22.33110Gap UpNNOXNano-X Imaging2.3376 of 5 stars$7.27-9.9%$17.50+140.7%+46.3%$420.05M$10.68M-8.55190News CoverageGap UpTCMDTactile Systems Technology3.6526 of 5 stars$17.31+0.5%$23.00+32.9%+25.8%$415.39M$285.05M26.63980Analyst DowngradeShort Interest ↑News CoverageDCTHDelcath Systems3.8327 of 5 stars$12.53+9.1%$21.50+71.6%+272.7%$400.58M$2.07M-9.2860Analyst ForecastShort Interest ↓News CoverageGap UpZIMVZimVie2.7536 of 5 stars$13.64+1.1%$19.50+43.0%-16.6%$376.45M$451.29M-1.042,700News CoveragePositive NewsCVRXCVRx1.7577 of 5 stars$15.07+6.4%$16.67+10.6%-34.0%$365.66M$47.26M-5.58160Upcoming EarningsAnalyst UpgradeAnalyst RevisionNews CoverageNPCENeuroPace3.5566 of 5 stars$12.12+1.5%$15.00+23.8%-9.7%$361.76M$76.45M-12.12170News Coverage Related Companies and Tools Related Companies OrthoPediatrics Competitors Treace Medical Concepts Competitors Semler Scientific Competitors ClearPoint Neuro Competitors Nano-X Imaging Competitors Tactile Systems Technology Competitors Delcath Systems Competitors ZimVie Competitors CVRx Competitors NeuroPace Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:NVRO) was last updated on 1/19/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nevro Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nevro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.